Lozacan

Creso Pharma set to benefit from OTC cannabidiol sales in Australia

Finfeed Archived Feb 01, 2021

Creso Pharma (ASX: CPH) is prepared to meet demand as OTC sales of low-dose cannabidiol products start in Australian pharmacies.